SXTC - China SXT Pharmaceuticals, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

SXTC

CHINA SXT PHARMACEUTICALS, INC.

NASDAQ

$3.00

▼ DOWN 13.29% (-0.46)

KEY STATISTICS

Market Cap$1.60 M

52w High$83760.00

52w Low$3.00

Dividend Yield—

Frequency—

P/E1.07

Volume116.26K

Shares Out.533.98K

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Feng Zhou

ABOUT

SECTOR

Healthcare

WENT PUBLIC

January 4, 2019

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
2026-08-10	Reverse	1:80
2026-02-03	Reverse	1:150
2025-02-25	Reverse	1:8
2023-10-05	Reverse	1:25
2022-05-19	Reverse	1:20
2021-02-22	Reverse	1:4

PRICE

$3.00 ▼ DOWN 13.29% (−$0.46)

OVERLAYS

About China SXT Pharmaceuticals, Inc.

http://www.sxtchina.com ↗

China SXT Pharmaceuticals, Inc. develops, manufactures, and sells traditional Chinese medicine products and raw materials in China, serving pharmacies, hospitals, and distributors under brands like Suxuantang and Tong Ren Tang.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT CHINA SXT PHARMACEUTICALS, INC. IS KNOWN FOR

Zhudanfen Directly-Oral TCMP

Zhudanfen Directly-Oral TCMP is an innovative, decoction-free Chinese medicine for cough, asthma, and sore throat, recently developed by the company and included in China's National Medical Insurance Catalogue.